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Abstract
Background: matrix metalloproteinases (MMPs) are produced by tumor cells, so they may be associated with
tumor progression including invasion, migration, angiogenesis and metastasis. Aquaporin-3 (AQP3) also plays a
critical role in gastric cancer cell migration and proliferation.
Methods: In this study, AQP3 was silenced or over-expressed in SGC7901 cells.
Results: We found a significant decrease in MT1-MMP, MMP-2, and MMP-9 expression after AQP3 knockdown, and
a significant increase in MT1-MMP, MMP-2, and MMP-9 expression after AQP3 over-expression in SGC7901 cells. We
also found that AQP3 silence led to a significant decrease of phosphorylation of ser
473 in AKT in SGC7901 cells.
Conclusion: Our findings showed that AQP3 might positively regulate MMPs proteins expression through PI3K/AKT
signal pathway in human gastric carcinoma SGC7901 cells.
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Background
Gastric cancer (GC) remains a major cause of mortality
and morbidity worldwide [1]. The rapid invasion and
metastasis of tumor cells are responsible for poor prog-
nosis [2]. The high expression of MMPs in GC tissues
has been determined in several studies [3,4]. It has
shown that MMPs expression correlates with clinical
pathological features of GC, such as tumor stage, depth
of tumor invasion and the presence of lymph node and
distant metastases [5].
Aquaporins (AQPs) are a family of small (30 kDa/
monomer) hydrophobic, integral membrane proteins,
which belong to a special superfamily of membrane inte-
gral proteins called MIPs (major intrinsic proteins) [6,7].
In our previous work, we showed a differential expression
of AQPs between human gastric carcinomas and corre-
sponding normal tissue, and the association of AQP3
expression with the lymph node metastasis and lympho-
vascular invasion of human gastric carcinoma [8].
The PI3K signal pathway plays an integral role
in many normal cellular processes, including survival,
proliferation, differentiation, metabolism and motility, in
a variety of cell types. Although a number of studies
have convincingly demonstrated that the PI3K/AKT
pathway regulated MT1-MMP activity,[9] but the mole-
cular mechanisms are still unclear. Here, we reported
that AQP3 positively regulated MMPs proteins expres-
sion through PI3K/AKT signal pathway in human
gastric carcinoma cells.
Materials and Methods
Cell culture
Human gastric cancer cell line (SGC7901) were kindly
provided by Shanghai Institute of Cell Biology, Chinese
Academy of Sciences (Shanghai, China) and were grown
in DMEM supplemented with 10% fetal bovine serum
(FBS), 100 μg/ml streptomycin and 100 units/ml penicil-
lin at 37 °C in a humidified incubator in an atmosphere
of 5% CO2.
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Rabbit anti-AQP3 antibody was obtained from Santa
Cruz Biotechnology (Santa Cruz, CA). Antibodies
against total AKT, Ser
473 phosphorylated AKT, and
b-actin were supplied by Cell Signaling Technology
(Beverly, MA, USA). Lentiviral vectors encoding AQP3
and the shRNA (more than four sequences) for
AQP3 were designed and chemically synthesized by
Genephama Biotech(Shanghai, China). LY294002, MT1-
MMP, MMP-2, and MMP-9 antibodies were purchased
from Abcam (Hong Kong, China).
Lentiviral transfection
ShRNA of human AQP3 lentivirus gene transfer vector
encoding green fluorescent protein(GFP) and puromycin
sequence was constructed by Genephama Biotech
(Shanghai, China). The lentiviral-scrambled-shRNA
served as negative control. For shRNA of human AQP3,
the oligonucleotide sequences were GGCTGTATTAT-
GATGCAATCT. The aqp3shRNA was packaged with
lentivirus following the manufacturer’s protocols. When
SGC7901 cells grew to 60-70% confluence, the cells
were infected with lentiviral-scrambled-shRNA or lenti-
viral vector encoding AQP3 at a multiplicity of infection
(MOI) of 20. Stable cell lines were selected with 2 μg/ml
puromycin (Sigma-Aldrich) for one week. After that,
cells were analyzed using quantitative RT-PCR and
Western blot for AQP3 expression.
Reverse transcription and real-time PCR
Total RNA was extracted from the cells using the Trizol
reagent (Invitrogen, Carlsbad, Calif) and exactly follow-
ing the manufacturer’s manual under RNase-free condi-
tion. After complementary DNA was synthesized with a
two-step reverse transcription reaction kit(TAKARA,
Dalian, China), quantitative PCR was performed on an
Applied Biosystems 7500 Real-time PCR System using
SYBR Premix Ex Taq Kit (TAKARA, Dalian, China) in
Axygen 96-well reaction plates following the manufac-
turer’sp r o t o c o l s .b-actin was used as a reference to
obtain the relative fold change for target samples using
the comparative Ct method. The primers used are as
follows: b-actin forward, TCACCCACACTGTGCC-
CATCTACGA; b-actin reverse, CAGCGGAACCGCT-
CATTGCCAATGG, AQP3 forward, CACAGCCGGC
ATCT- TTGCTA, reverse, TGGCCAGCACACACAC-
GATA, All cell preparations and real-time PCRs were
performed in triplicate.
Western blot analysis
For Western blot, cells were reseeded in 6-well plates at
a density of 0.2 × 10
6 cells/ml with fresh complete cul-
ture medium. Cells with or without treatment were
washed with cold PBS and harvested by scraping into
150 μl of RIPA buffer(containing 50 mM Tris-HCl, pH
7.4, 150 mM NaCl, 1% NP-40, 1 mM EDTA 0.25% sodium
deoxycholate) with 1mM NaF, 10 μMN a 3 V O 4 ,1m M
PMSF, and a protease inhibitor concoction(10 μg/ml leu-
peptin, 10 μg/ml aprotinin, and 1 μM pepstatin). Cell
lysates were incubated at 4°C for 30 min. After centrifuga-
tion at 12,000 rpm for 20 min at 4°C, protein concentra-
tions were determined by bicinchoninic acid(BCA) protein
assay. Forty micrograms of proteins(for AQP3, MT1-
MMP, MMP-2, MMP-9, phospho-AKT or AKT) were
denatured in 5× SDS-PAGE sample buffer for 5 min at
100°C. The proteins were separated by 12% SDS-PAGE
and transferred onto PVDF membrane(Millipore, Bedford,
MA) for 90 min at 4°C. Nonspecific binding was blocked
with 5% dry skimmed milk in TBST (20 Mm Tris-HCl,
137 mM NaCl, 0.1% Tween 20, pH 7.4) for 2 h at room
temperature. After blocking, membranes were incubated
with specific antibodies against AQP3(1:500), MT1-MMP
(1:1,000), MMP-2(1:1,000), MMP-9(1:1,000), phospho-
AKT(1:1,000), or AKT(1:1,000) in dilution buffer (2% BSA
in TBS) overnight at 4°C. The blots were incubated with
HRP-conjugated anti-mouse or anti-rabbit IgG (1:2,000) at
room temperature for 2 h. Antibody binding was detected
using an enhanced chemiluminescence(ECL) detection
system following manufacturer’s instructions and visua-
lized by autoradiography with Hyperfilm. Semiquantita-
tively analyzed of the blots were acquired using the
software Quantity One(BioRad, USA). The density for
AQP3, MMPs, or phospho-AKT protein in their parental
sample was normalized to 1.0, and the values for other
treatments were calculated against this value.
Statistical analysis
All data were expressed as mean ± SD. Statistical ana-
lyses were performed using Student’s t test or analysis
of variance (ANOVA). The values of P < 0.05 are con-
sidered significant.
Results
AQP3 expression in SGC7901 cells after lentiviral
transfection
We examined the expression of AQP3 at its mRNA and
protein levels by performing quantitative RT-PCR and
Western blot analysis in SGC7901 cells. After transfec-
tion of aqp3shRNA, stable cell lines were harvested for
quantitative RT-PCR and Western blot analysis. After
transfection of lentiviral vector encoding AQP3, cells
were collected for quantitative RT-PCR and Western
blot analysis too. AQP3 mRNA and protein were
expressed in SGC7901 cells. After RNAi, both AQP3
mRNA and protein expression decreased significantly.
After transfection of lentiviral vector encoding AQP3,
both AQP3 mRNA and protein expression increased
obviously. (Figure 1)
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SGC7901 cells
The levels of MT1-MMP, MMP-2, and MMP-9 protein
expression were detected by Western blot analysis. A
significant decrease in MT1-MMP, MMP-2, and MMP-
9 expression was observed in AQP3 knockdown group
compared with control group. (Figure 2)
AQP3 over-expression up-regulated MMPs expression
in SGC7901 cells
The levels of MT1-MMP, MMP-2, and MMP-9 protein
expression were detected by Western blot analysis. A
significant increase in MT1-MMP, MMP-2, and MMP-9
expression was observed in AQP3 over-expression
group compared with control group. (Figure 3)
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Figure 1 The expression level of AQP3 in SGC7901 in real-time PCR and Western blot studies. AQP3 mRNA and protein were expressed
in SGC7901 cells. After RNAi, both AQP3 mRNA and protein expression decreased significantly. After transfection of lentivector encoding AQP3,
both AQP3 mRNA and protein expression levels were increased obviously. The expression levels of different cells were further normalized to that
of BLANK group, making the relative expression level of BLANK group as 100%.
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Figure 2 AQP3 regulated MMPs expression in SGC7901 cells. AQP3 silence down-regulated MMPs expression in SGC7901 cells. AQP3
regulated MMPs expression in SGC7901 cells. AQP3 silence down-regulated MMPs expression in SGC7901 cells. A significant decrease in MT1-
MMP, MMP-2, MMP-9 expression was observed in AQP3 knockdown group compared with control group.* p < 0.05 BLANK control SGC7901
cells NC cells treated with scrambled shRNA aqp3shRNA cells treated with aqp3shRNA
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To determine whether the PI3K/AKT pathway was
involved in the AQP3 silence down-regulated MMPs
expression SGC7901 cells, we first compared levels of
phosphorylated and total AKT in SGC7901 cells treated
with AQP3 interference by using Western blot. AQP3
silence led to a significant decrease in phosphorylation
of ser
473 in AKT. (Figure 4)
AQP3 up-regulation activated PI3K/AKT
pathway in SGC7901 cells
We compared levels of phosphorylated and total AKT
in SGC7901 cells with AQP3 over-expression by using
Western blot. AQP3 over-expression led to a signifi-
cant increase in phosphorylation of ser
473 in AKT.
(Figure 5)
LY294002 down-regulated MMPs expression in SGC7901
cells
SGC7901 cells were exposed to 20 μM LY294002 for
48 h (fresh media containing LY294002 was added every
24 h), and then were harvested to perform Western
blot. We found a significant decrease in MT1-MMP,
MMP-2, and MMP-9 expression. However, with the
addition of LY294002, the expression of MMPs could
not be obviously reversed in LV-AQP3 or aqp3shRNA
groups. (Figure 6)
Discussion
Recent studies showed that the involvement of AQPs in
angiogenesis and tumor cell migration and proliferation
had potentially important clinical implication [10,11].
We reported for the first time that AQP4 protein and
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Figure 3 AQP3 regulated MMPs expression in SGC7901 cells. AQP3 over-expression up-regulated MMPs expression in SGC7901 cells. A
significant increase in MT1-MMP, MMP-2, MMP-9 expression was observed in AQP3 over-expression group compared with control group.* p <
0.05 BLANK control SGC7901 cells NC cells treated with scrambled shRNA LV-AQP3 cells treated with lentiviral vector encoding AQP3.
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Figure 4 AQP3 regulated PI3K/AKT pathway in SGC7901 cells. AQP3 silence blocked PI3K/AKT pathway in SGC7901 cells. AQP3 silence led
to a significant decrease in phosphorylation of ser
473 in AKT. * p<0.05 BLANK control SGC7901 cells NC cells treated with scrambled shRNA
aqp3shRNA cells treated with aqp3shRNA.
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significantly lower than those in normal gastric tissue
[12]. Then, we demonstrated that AQP3 played a critical
role in gastric cancer cell migration and proliferation in
previous study [13]. In this study, we found that AQP3
silence could down-regulate MMPs expression and
AQP3 over-expression could up-regulate MMPs expres-
sion in SGC7901 cells.
Many tumors exhibit elevated levels of MMPs, which
may play an important role in cellular invasion and
metastasis [14]. Among the human MMPs reported to
date, MT1-MMP, MMP-2 and MMP-9 are the major
enzymes involved in degrading types I and IV collagen
and the extracellular matrix(ECM) [15]. Tumor-secreted
MMPs destroy the ECM components in tissues sur-
rounding a tumor, enabling tumor cells to pass through
the basement membrane of blood vessels and facilitating
their spread to distant organs, resulting in organ failure
and patient mortality. MT1-MMP, MMP-2 and MMP-9,
which are abundantly expressed in various malignant
tumors, contribute to cancer invasion and metastasis
[15].
In our study, AQP3 over-expression could up-regu-
lated MMPs expression in SGC7901 cells. Hwang et al.
and Kajanne et al. indicated that MMPs could be sti-
mulated by an inflammatory cytokine, epidermal
growth factor (EGF), through the activation of different
intracellular signal pathways [16,17]. This was consis-
tent with our results. We supposed that AQP3 might
be involved in MMPs stimulatory pathway in SGC7901
cells.
PI3K/AKT signal pathway was found abnormally acti-
vated and closely associated with tumorigenesis and
tumor progression [18]. AKT is a key regulator of cell
survival and apoptosis, increased AKT phosphorylation
has been reported in a variety of cancers [19]. Our
results showed that AKT was phosphorylated excessively
and AQP3 silence led to a significant decrease in phos-
p h o r y l a t i o no fs e r 4 7 3i nA K Ti nS G C 7 9 0 1c e l l s .
LY294002 is a specific inhibitor of PI3K, and is generally
used in research on PI3K/AKT signal pathway. After
treatment with LY294002, the p-AKT expression levels
in SGC7901 cells decreased obviously, suggesting its
p-AKT 
AKT 
LV-AQP3  BLANK  NC 
Figure 5 AQP3 regulated PI3K/AKT pathway in SGC7901 cells. AQP3 over-expression activated PI3K/AKT pathway in SGC7901 cells. AQP3
over-expression led to a significant increase in phosphorylation of ser
473 in AKT. * p < 0.05 BLANK control SGC7901 cells NC cells treated with
scrambled shRNA LV-AQP3 cells treated with lentiviral vector encoding AQP3.
Figure 6 LY294002 down-regulated MMPs expression and
blocked the effect of LV-AQP3 and aqp3shRNA in SGC7901
cells. SGC7901 cells were exposed to LY294002 for 48h and then
were harvested to perform Western blot analysis. We found a
significant decrease in MT1-MMP, MMP-2, and MMP-9 expression.
However, with the addition of LY294002, the expression of MMPs
could not be obviously reversed in LV-AQP3 or aqp3shRNA groups.
* p < 0.05 BLANK control SGC7901 cells NC cells treated with
scrambled shRNA LY294002 cells treated with LY294002 LY294002
+LV-AQP3 cells treated with LY294002 and LV-AQP3 LY294002
+aqp3shRNA cells treated with LY294002 and aqp3shRNA
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by suppressing AKT phosphorylation catalyzed by PI3K.
Meanwhile, LY294002 could decrease MT1-MMP,
MMP-2, and MMP-9 expression in SGC7901 cells.
However, with the addition of LY294002, the expression
of MMPs could not be obviously reversed in LV-AQP3
or aqp3shRNA groups. And this result is a further evi-
dence of the involvement of PI3K/AKT pathway in
AQP3 regulating MMPs.
In conclusion, our findings emphasize that AQP3
might up-regulate MMPs proteins expression via the
PI3K/AKT signal pathway in human gastric carcinoma
SGC7901 cells.
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